Charles River Laboratories | CRL - Stammkapital

Aktienkurs
169.54
Täglich Wechseln
1.32 0.78%
Monatlich
-4.21%
Jährlich
37.16%
Q2 Prognose
168.66




Stammkapital Veränderung Datum
Agilent USD 282.7M 358K 2025-12
Align Technology USD 71.75M 736K 2025-12
Bio-Rad Laboratories USD 26.97M 90K 2025-09
Bruker USD 151.94M 225K 2025-12
Cardinal Health USD 238M 1000K 2025-09
Charles River Laboratories USD 49.22M 2K 2025-12
Cigna USD 263.46M 3.14M 2025-12
Concord Medical Services Hldg CNY 130.25M 130.15M 2025-06
CVS Health USD 1.27B 1000K 2025-12
Danaher USD 706.9M 600K 2025-12
Dentsply International USD 199.5M 196.5M 2025-09
Elevance Health USD 222.24M 2.94M 2025-12
Galapagos EUR 65.9M 0 2025-12
Hologic USD 222.57M 350K 2025-09
Humana USD 120.59M 318K 2025-12
Illumina USD 152.8M 900K 2025-12
Incyte USD 198.46M 2.33M 2025-12
Intrexon USD 0 0 2024-06
IQVIA Holdings USD 169.6M 700K 2025-12
Laboratory Of America USD 82.2M 700K 2025-12
Lonza CHF 68.64M 0 2025-12
McKesson USD 280M 156M 2025-12
Merck EUR 434.78M 0 2025-12
Mettler Toledo International USD 20.43M 170.6K 2025-12
Novartis USD 1.91B 10.64M 2025-12
Pfizer USD 5.69B 1000K 2025-09
Quest Diagnostics USD 110M 1000K 2025-12
Revvity USD 113.38M 2.7M 2025-12
Thermo Fisher Scientific USD 375.71M 1.9M 2025-12
United Therapeutics USD 43.64M 740K 2025-12
UnitedHealth USD 905.84M 161K 2025-12
Veradigm USD 106.07M 103.28M 2022-12
Waters USD 98.08M 38.55M 2025-12
West Pharmaceutical Services USD 72M 100K 2025-12